Kavisha S. Jayasundara
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.
Journal: Vaccines
Published: January 17, 2024
Estimating the clinical cost of drug development for orphan versus non-orphan drugs.
Journal: Orphanet journal of rare diseases
Published: June 05, 2018
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology.
Journal: PharmacoEconomics - open
Published: February 15, 2018
Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese.
Journal: Journal of pharmaceutical sciences
Published: April 20, 2017
Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada.
Journal: Leukemia research
Published: October 31, 2016
Cost Effectiveness of Ofatumumab Plus Chlorambucil in First-Line Chronic Lymphocytic Leukaemia in Canada.
Journal: PharmacoEconomics
Published: November 01, 2015
Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis.
Journal: BMC infectious diseases
Published: April 25, 2014
Risk of failure of a clinical drug trial in patients with moderate to severe rheumatoid arthritis.
Journal: The Journal of rheumatology
Published: September 04, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026